Consistently, we have demonstrated that dedifferentiated melanoma cells express inflammation-related genes such as pentraxin 3 (PTX3), which contribute to melanoma invasiveness and the mesenchymal-resistant phenotype via a Toll-like receptor 4 (TLR4)-NF-κB-TWIST pathway [109]. The gene discussed is TLR4; the disease is melanoma.